Efficacy and Safety Evaluation of Azimilide or Sotalol vs Placebo for Treatment of Patients With Atrial Fibrillation.

NCT ID: NCT00035451

Last Updated: 2011-10-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

658 participants

Study Classification

INTERVENTIONAL

Study Start Date

2001-02-28

Study Completion Date

2003-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Atrial fibrillation (abnormal rhythm in the upper chamber of the heart) is a common supraventricular arrhythmia (a type of abnormal heart rhythm) for which antiarrhythmic therapy is often prescribed. The primary goals of therapy are to maintain sinus rhythm (normal heart rhythm) and to reduce the occurrence of episodes of atrial fibrillation.

The double-blind, placebo-controlled phase of this study is designed to evaluate the efficacy and safety of oral azimilide compared with placebo and with sotalol, an antiarrhythmic drug, in maintaining sinus rhythm in patients who require cardioversion (electric shock to correct heart rhythm) to correct atrial fibrillation. Once this phase of the study is completed, a second phase with a different study design will be conducted. The second phase is an open-label, follow-up phase to the first study. The follow-up phase will continue to evaluate the long-term safety of a daily oral dose of azimilide in patients who complete the double-blind, placebo-controlled phase of this study.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Atrial Fibrillation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

placebo tablets

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type DRUG

tablets, twice daily for 6 months

2

Sotalol

Group Type ACTIVE_COMPARATOR

Sotalol

Intervention Type DRUG

160 mg sot twice daily for 6 months

3

azimilide

Group Type EXPERIMENTAL

Azimilide Dihydrochloride

Intervention Type DRUG

125 mg azimilide tablets, twice a day for 6 months

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Azimilide Dihydrochloride

125 mg azimilide tablets, twice a day for 6 months

Intervention Type DRUG

Placebo

tablets, twice daily for 6 months

Intervention Type DRUG

Sotalol

160 mg sot twice daily for 6 months

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Documented (12-lead ECG) history of symptomatic atrial fibrillation occurring between 48 hours and 6 months before screening
* Require the procedure of cardioversion (electric shock to correct abnormal rhythm)
* In the investigator's opinion, is likely to maintain sinus rhythm after cardioversion.
* Be anticoagulated according to the recommendations of the Study Group on Atrial Fibrillation of the European Society of Cardiology guidelines.

Exclusion Criteria

* Previously unsuccessful electrical cardioversions
* Failed to respond to any Class III antiarrhythmic drugs
* Qualifying arrhythmia due to acute reversible illness, acute myocardial infarction, and/or cardiac or thoracic surgery within one month prior to randomization
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Forest Laboratories

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Paloma Cuenca, MD

Role: STUDY_DIRECTOR

Procter and Gamble

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Clinique Generale Saint Jean Service de cardiologie

Brussels, , Belgium

Site Status

Hospital Universitarie Erasme

Brussels, , Belgium

Site Status

Cliniques Univeristaires UCL Mont-Godinne Avenue Theresse 1

Yvoir, , Belgium

Site Status

Service de Cardilolgie CH du Pays d'Aix

Aix-en-Provence, , France

Site Status

CHR Besancon Service de cardiologie

Besançon, , France

Site Status

Hopital Gavriel Montpied Cardiologie-Maladie cardiovascularies

Clermont-Ferrand, , France

Site Status

Service de Cardiologie CHRU

Grenoble, , France

Site Status

Cardiologie Hopital Jean Rostand

Ivry-sur-Seine, , France

Site Status

Service de Cardiologie A Hopital Cardiologique

Lille, , France

Site Status

Service de Cardiologie Hopital Saint Philibert

Lomme, , France

Site Status

Cardilolgie Hopital Guillaume et Rene Laennec

Nantes, , France

Site Status

Service de Cardiologie Hopital Lariboisiere

Paris, , France

Site Status

Service de Cardiologie et Maladies Vascularies CHRU Pontchaillou

Rennes, , France

Site Status

Cardiologie CHRU St Etienne/Hopital Nord

Saint-Etienne, , France

Site Status

Centre Hospitalier General Hospital De Girac

Saint-Michel-sur-Orge, , France

Site Status

Cardiologie/Pavillon Baudot Centre Hospitalier Universitaire Purpan

Toulouse, , France

Site Status

Cardiologie A CHU Rangueil

Toulouse, , France

Site Status

Service de cardiologie Hopitaux de Brabois/CHRU Nancy

Vandœuvre-lès-Nancy, , France

Site Status

Erzgebirgskrankenhaus Klinik fur Innere Medizin

Annaberg, , Germany

Site Status

Kerckhhoff-Klinik Abteilung Klinische Pharmakologie

Bad Nauheim, , Germany

Site Status

Kardiologie Herzzentrum Osnabruck

Bad Rothenfelde, , Germany

Site Status

Dr. Schreiber Krankenhaus Neukoelin 1 Innere Rudowerstrasse, 48

Berlin, , Germany

Site Status

Franz-Volhard-Klinik Abteilung fur Elektrophysiologie

Berlin, , Germany

Site Status

Stadisches Klinikum Brandenburg Med-Klinik I/Kardiologie Pulmologie und Angiologie

Brandenburg, , Germany

Site Status

Klinikum Coburg II Med. Klinik

Coburg, , Germany

Site Status

Klinkum Lippe-Detmold Med. Klink II-Kardiologie

Detmold, , Germany

Site Status

Krankenhaus Duren Medizinische Klinik I Kardiologie/Angiologie

Düren, , Germany

Site Status

Klinikum Erfurt GmbH

Erfurt, , Germany

Site Status

Medizinische Universitaetsklinik Innere Medizin III Kardiologie und Angiologie

Frieburg, , Germany

Site Status

Universitatsklinikum Hamburg-Eppendork Klinik und Poliklinik fur Innere Medizin Abteilung Kardiologie

Hamburg, , Germany

Site Status

Medizinische Hochschule Innere Medizin/Abt. fur Kardiologie

Hanover, , Germany

Site Status

Universitatsklinikum Heidelberg

Heidelberg, , Germany

Site Status

Medizinische Universitats-und Ploiklinik Innere Medizin 3

Homburg, , Germany

Site Status

Klinikum Kassel Medizinische Klinik II

Kassel, , Germany

Site Status

Universitate zu Koeln Klinik III fur Innere Medizin

Koeln (Lindenthal), , Germany

Site Status

Universitat Leipzig Medizinische Klinik und Poliklinik 1 Abteilung fur Kardiologie and Angiolgie

Leipzig, , Germany

Site Status

Klinikum der Stadt Ludwigshafen Abteilung fur Elektrophysiologie der Kardiologie/Herzzentrum

Ludwigshafen, , Germany

Site Status

Medizinische Klinik und Poliklnik Innere Medizin C

Mannheim, , Germany

Site Status

Medizinische Klinik und Poliklinik Innere Medizin C

Münster, , Germany

Site Status

Klinik am See REHA-Zentrum fur Herz und Kreislauf

Rüdersdorf, , Germany

Site Status

Medizinische Universitat Tubingen Med. Klinik III, Abt. III fur Kardiologie

Tübingen, , Germany

Site Status

Reinhard-Nieter-Krankenhaus Med. Klinik 1

Wilhelmshafen, , Germany

Site Status

State Hospital

Balatonfüred, , Hungary

Site Status

Gottsegen Gyorgy National Institute of Cardiology

Budapest, , Hungary

Site Status

Szent Imre Hospital, Dept. of Internal MedicineI.

Budapest, , Hungary

Site Status

Semmelweis University, Dept. of Internal Medicine III.

Budapest, , Hungary

Site Status

National Institiute of Pulmonology, Dept. of Cardiology

Budapest, , Hungary

Site Status

Toldi Ferenc Hospital, Dept. of Internal Medicine II.

Cegléd, , Hungary

Site Status

Debrecen City Health Service

Debrecen, , Hungary

Site Status

Markoth Ferenc County Hospital

Eger, , Hungary

Site Status

Pandy Kalman Hospital

Gyula, , Hungary

Site Status

County Hospital, Dept. of Internal Medicine I.

Kecskemét, , Hungary

Site Status

Miskolc County Hospital

Miskolc, , Hungary

Site Status

Mosonmagyarovar City Karolina Hospital

Mosonmagyaróvár, , Hungary

Site Status

University of Pecs, Cardiology Clinic

Pécs, , Hungary

Site Status

Siofok City Hospital

Siófok, , Hungary

Site Status

Allami Szanatorium

Sopron, , Hungary

Site Status

County Hospital, Dept. of Internal Medicine

Szentes, , Hungary

Site Status

Szent Gyorgy Hospital

Székesfehérvár, , Hungary

Site Status

Markusovszky Hospital, Dept. of Internal Medicine III.

Szombathely, , Hungary

Site Status

Divisione di Cardiologia Ospedale Civile

Asti, , Italy

Site Status

Cardiovascular Disease Unit University of Bari-Ploiclinico

Bari, , Italy

Site Status

Azienda Ospedaliera "Garibaldi S, Luigi Ascoli Tomaselli" Servizio di Cardiologia

Catania, , Italy

Site Status

Servizio di Cardiologia Azienda Ospedaliera S. Anna

Como, , Italy

Site Status

Cardiology Division Hospital "Santa Croce e Carle"

Cuneo, , Italy

Site Status

Department of Internal Medicine (DIMI) University of Genova

Genova, , Italy

Site Status

Ospedale Civile Umberto I Cardiology Division

Mestre, , Italy

Site Status

S. Paolo Hospital University of Milan Department of Cardiology

Milan, , Italy

Site Status

Cardiology Unit University of Naples "Frederico II"

Napoli, , Italy

Site Status

Cardiology Unit Policlinico S. Matteo

Pavia, , Italy

Site Status

Osp. Civile di Piacenza-Div. di Cardiologia

Piacenza, , Italy

Site Status

Dep. of Cardiovascular and Respiratory Diseases Policlinico Umberto I

Roma, , Italy

Site Status

Ospedale Umberto I di Torino

Torino, , Italy

Site Status

Catharina Ziekenhuis Afd. Cardilolgie

Eindhoven, , Netherlands

Site Status

Kennemer Gasthuis

Haarlem, , Netherlands

Site Status

Isala Klinieken Locatie De Weezenlanden

JW Zwolle, , Netherlands

Site Status

Academisch Ziekenhuis Maastricht Afdeling Cardiologie

Maastricht, , Netherlands

Site Status

Department Cardiology Canisius Wilhelmina Hospital

Nijmegen, , Netherlands

Site Status

St Elisabeth Ziekenhuis Afdeling Cardiologie

Tilburg, , Netherlands

Site Status

Klinika Gastroenterologii i Chorob Wewnetrznych Szpital Wojewodzki Zespolony im. Biziela

Ul Ujejskiego 75, Bydgoszcz, Poland

Site Status

Oddizial Kardiologii Wojewodzki Szpital Zespolony

Ul Ujejskiego 75, Bydgoszcz, Poland

Site Status

Samodzielny Publiczny Szpital Kliniczny Klinika Kardiologii

Bialystok, , Poland

Site Status

I Klinika Chorob Serca Instytut Kardiologii AM

Gdansk, , Poland

Site Status

Gornoslaskie Centrum Medyczne I Klinika Kardiologii

Katowice, , Poland

Site Status

Szpital Wojewodzki Oddzial Kardiologii

Kielce, , Poland

Site Status

Instytut Kardiologii CMUJ Klinika Choroby Wiencowej

Krakow, , Poland

Site Status

Oddzial Kardilolgii Wojewodski Szpital Specjalistyczny

Olsztyn, , Poland

Site Status

Oddzial Kardiologii Wojewodzkie Centrum Medyczne

Opole, , Poland

Site Status

Oddizial Wewnetzny Szpital Miejski

Ostrowiec Świętokrzyski, , Poland

Site Status

Oddzial Kardiologii Wojewodzki Szpital Zespolony

Płock, , Poland

Site Status

Radomski Szpital Specjalistyczny Oddzial Kardiologii

Radom, , Poland

Site Status

Oddizial Kardiologii Szpital Wojewodzki nr 2

Rzeszów, , Poland

Site Status

Samodzielny Publiczny Szpital Zespolony Oddizial Kardiologii

Szczecin, , Poland

Site Status

Wojewodzki Szpital Zespolony Oddzial Kardilolgii

Torun, , Poland

Site Status

I Klinika Kardiologii CSK WAM

Warsaw, , Poland

Site Status

Szpital Wolski im. Dr Anny Gostynskiej Oddzial Kardiologii

Warsaw, , Poland

Site Status

Instytut Kardiologii

Warsaw, , Poland

Site Status

Klinika Kardiologii IV Wojskowy Szpital Kliniczny

Wroclaw, , Poland

Site Status

Oddzial Kardiologii Szpital Wojewodzki

Zamość, , Poland

Site Status

Cardiology Department, Moscow Clinical Hospital No. 59

Moscow, , Russia

Site Status

Res. Inst. of Physical and Chemical Medicine Department of Cardiology Moscow Clinical Hospital No. 29

Moscow, , Russia

Site Status

Russian State Medical University Clinical facility: Cardiology Department of City Clinical Hospital No. 4

Moscow, , Russia

Site Status

Moscow State Institute of Peace and Friendship Pharmacology Department, Moscow Clinical Hospital #64

Moscow, , Russia

Site Status

Cardiology Department Moscow Sechenov Medical Academy

Moscow, , Russia

Site Status

Medical Centre of General Management Department of the President of the Russian Federation, Cardiology Department Moscow Clinical Hospital No. 51

Moscow, , Russia

Site Status

Medical Centre of General Management Department of the President of the Russian Federation

Moscow, , Russia

Site Status

Cardiology Department of State Medical Academy of Postgraduate Education, Myasnikov Clinical Cardiology Research Institute

Moscow, , Russia

Site Status

Department of Emergency Cardiology Russian Cardiology Research Centre

Moscow, , Russia

Site Status

Moscow State University of Medicine and Stomatolog, Cardiology Department of Moscow Clinical Hospital No. 50

Moscow, , Russia

Site Status

Department of Internal Disease No. 5, Moscow State University of Medicine and Stomatology, Cardiology Department Moscow City Hospital No. 11

Moscow, , Russia

Site Status

Myocardial Infarction Department St Petersburg Hospital, No. 28

Saint Petersburg, , Russia

Site Status

Cardiology Department, State Research Institute

Saint Petersburg, , Russia

Site Status

Cardiology Department Alexandrovskiy Hospital

Saint Petersburg, , Russia

Site Status

Cardiology Department St Petersburg Hospital No. 2

Saint Petersburg, , Russia

Site Status

Myocardial Infarction Department St Elizabeth Hospital

Saint Petersburg, , Russia

Site Status

Cardiology Department St. Petersburg State Pavlov Medical University

Saint Petersburg, , Russia

Site Status

Myocardial Infarction Department St Petersburg Hodpital, No. 29

Saint Petersburg, , Russia

Site Status

Cardiology Department, St Petersburg Hospital, No. 15

Saint Petersburg, , Russia

Site Status

Department of Cardiology No. 3 Pokrovskiy Hospital

Saint Petersburg, , Russia

Site Status

Hospital Universitari San Juan Servicio di Cardiologia

Alicante, , Spain

Site Status

Hospital Valle de Hebron Servicio de Cardiologia

Barcelona, , Spain

Site Status

Hospital Princeps d'Espanya (Bellvitge) Servicio de cardiologia

Barcelona, , Spain

Site Status

Hospital Civil De Basurto Cardiology Service

Basurto-Bilbao, , Spain

Site Status

Hospital Nuestra Senora de Alarcos Unidad de Medicina Intensiva

Ciudad Real, , Spain

Site Status

Hospital Universitario De Getafe Cardiology Service

Getafe, , Spain

Site Status

Fundacion Jimenez Diaz Cardiology Service

Madrid, , Spain

Site Status

Hospital Clinico Universitario San Carlos Servicio de Cardiologia

Madrid, , Spain

Site Status

Hospital La Paz U.M.Q. de cardiologia

Madrid, , Spain

Site Status

Hospital de Txagorritxu

Vitoria-Gasteiz, , Spain

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Belgium France Germany Hungary Italy Netherlands Poland Russia Spain

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1999105

Identifier Type: -

Identifier Source: org_study_id